n-methyl-3,4-methylenedioxyamphetamine has been researched along with Liver Failure, Acute in 15 studies
N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.
Liver Failure, Acute: A form of rapid-onset LIVER FAILURE, also known as fulminant hepatic failure, caused by severe liver injury or massive loss of HEPATOCYTES. It is characterized by sudden development of liver dysfunction and JAUNDICE. Acute liver failure may progress to exhibit cerebral dysfunction even HEPATIC COMA depending on the etiology that includes hepatic ISCHEMIA, drug toxicity, malignant infiltration, and viral hepatitis such as post-transfusion HEPATITIS B and HEPATITIS C.
| Excerpt | Relevance | Reference |
|---|---|---|
| "On day 7 she developed fulminant hepatic failure with reduced hepatic coagulation factors and grade IV encephalopathy." | 2.40 | Liver transplantation for the treatment of fulminant hepatic failure induced by the ingestion of ecstasy. ( Beckurts, KT; Brauer, RB; Heidecke, CD; Hölscher, AH; Nathrath, W; Schweigart, U; Siewert, JR; Vorwald, P; Zilker, TR, 1997) |
| "When a young adult presents with fulminant hepatic failure of sudden onset, ecstasy consumption must be considered." | 1.33 | Non-paracetamol drug-induced fulminant hepatic failure among adults in Scotland. ( Garden, OJ; Simpson, KJ; Smith, ID; Wigmore, SJ, 2005) |
| "Within 10 days the patient developed acute liver failure." | 1.31 | [Acute liver failure following the use of ecstasy (MDMA)]. ( Berg, T; Fliege, H; Klapp, BF; Lange-Brock, N; Mönnikes, H; Müller, AR; Neuhaus, P; Wiedenmann, B, 2002) |
| "The suspected diagnosis was acute liver failure after "ecstasy" intake." | 1.30 | [Auxiliary liver transplantation for acute liver failure after intake of 3,4-methylenedioxymethamphetamine ("Ecstasy")]. ( de Groot, H; Erhard, J; Hellinger, A; Rauen, U, 1997) |
| "Four patients presented with acute liver failure without hyperthermia." | 1.29 | Acute liver damage and ecstasy ingestion. ( Ellis, AJ; Portmann, B; Wendon, JA; Williams, R, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (40.00) | 18.2507 |
| 2000's | 6 (40.00) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maharaj, R | 1 |
| Pingitore, A | 1 |
| Menon, K | 1 |
| Kane, P | 1 |
| Wendon, J | 1 |
| Bernal, W | 1 |
| Taş, A | 1 |
| Kara, B | 1 |
| Yılmaz, C | 1 |
| Suat Yalçın, M | 1 |
| Dilek, O | 1 |
| Olmez, S | 1 |
| Saritas, B | 1 |
| Mikuła, T | 1 |
| Kozłowska, J | 1 |
| Wiercińska-Drapało, A | 1 |
| Colak, Y | 1 |
| Tuncer, I | 1 |
| Enc, FY | 1 |
| Ozturk, O | 1 |
| Kiziltas, S | 1 |
| Ulasoglu, C | 1 |
| Lange-Brock, N | 1 |
| Berg, T | 1 |
| Müller, AR | 1 |
| Fliege, H | 1 |
| Neuhaus, P | 1 |
| Wiedenmann, B | 1 |
| Klapp, BF | 1 |
| Mönnikes, H | 1 |
| Ibrányi, E | 1 |
| Schönléber, J | 1 |
| Lukasik-Głebocka, M | 1 |
| Wachowiak, R | 1 |
| Kostrzewa, A | 1 |
| Karlikowski, M | 1 |
| Mańkowski, W | 1 |
| Kołowski, J | 1 |
| Smith, ID | 1 |
| Simpson, KJ | 1 |
| Garden, OJ | 1 |
| Wigmore, SJ | 1 |
| de Man, RA | 1 |
| Wilson, JH | 1 |
| Tjen, HS | 1 |
| Ellis, AJ | 1 |
| Wendon, JA | 1 |
| Portmann, B | 1 |
| Williams, R | 1 |
| Brauer, RB | 1 |
| Heidecke, CD | 1 |
| Nathrath, W | 1 |
| Beckurts, KT | 1 |
| Vorwald, P | 1 |
| Zilker, TR | 1 |
| Schweigart, U | 1 |
| Hölscher, AH | 1 |
| Siewert, JR | 1 |
| Hellinger, A | 1 |
| Rauen, U | 1 |
| de Groot, H | 1 |
| Erhard, J | 1 |
| Andreu, V | 1 |
| Mas, A | 1 |
| Bruguera, M | 1 |
| Salmerón, JM | 1 |
| Moreno, V | 1 |
| Nogué, S | 1 |
| Rodés, J | 1 |
| Friebe, M | 1 |
| Kindler, U | 1 |
| Diaz, V | 1 |
| Wyckoff, MM | 1 |
2 reviews available for n-methyl-3,4-methylenedioxyamphetamine and Liver Failure, Acute
| Article | Year |
|---|---|
Liver transplantation for the treatment of fulminant hepatic failure induced by the ingestion of ecstasy.
Topics: Adolescent; Adult; Female; Humans; Liver Failure, Acute; Liver Transplantation; Male; N-Methyl-3,4-m | 1997 |
Surviving fulminant hepatic failure.
Topics: Acute Disease; Adolescent; Anuria; Critical Care; Diagnosis, Differential; Female; Graft Rejection; | 2002 |
13 other studies available for n-methyl-3,4-methylenedioxyamphetamine and Liver Failure, Acute
| Article | Year |
|---|---|
Images of the Month: MDMA-Induced Acute Liver Failure and Transient Abdominal Pneumatosis.
Topics: Adult; Female; Heart; Humans; Ileus; Kidney; Lactic Acid; Liver; Liver Failure, Acute; N-Methyl-3,4- | 2015 |
Fulminant Budd-Chiari syndrome due to ecstasy.
Topics: Adult; Ascites; Budd-Chiari Syndrome; Diagnosis, Differential; Hallucinogens; Hepatomegaly; Humans; | 2017 |
Alcohol and ecstasy (MDMA-3,4-methylenedioxymethamphetamine) overdose as a reason for acute hepatitis with gall bladder inflammation.
Topics: Adolescent; Alcohol Drinking; Cholecystitis; Drug Overdose; Ethanol; Female; Humans; Liver Failure, | 2009 |
Ecstasy induced fatal hepatic failure.
Topics: Chemical and Drug Induced Liver Injury; Fatal Outcome; Hallucinogens; Humans; Liver Failure, Acute; | 2011 |
[Acute liver failure following the use of ecstasy (MDMA)].
Topics: Adolescent; Biopsy; Chemical and Drug Induced Liver Injury; Diagnosis, Differential; Female; Humans; | 2002 |
[Acute liver failure caused by Ecstasy].
Topics: Adrenergic Uptake Inhibitors; Adult; Autopsy; Fatal Outcome; Female; Humans; Liver Failure, Acute; N | 2003 |
[Clinical and toxicological evaluation of fatal poisoning with amphetamine derivative--MDMA, ecstasy (3,4-methylenedioxymethamphetamine)].
Topics: Acute Kidney Injury; Adolescent; Disseminated Intravascular Coagulation; Fatal Outcome; Humans; Live | 2004 |
Non-paracetamol drug-induced fulminant hepatic failure among adults in Scotland.
Topics: Adolescent; Adult; Age Distribution; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Ster | 2005 |
[Acute liver failure caused by methylenedioxymethamphetamine ('ecstasy')].
Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Chemical and Drug Induced Liver Injury; Combined Modality | 1993 |
Acute liver damage and ecstasy ingestion.
Topics: Adolescent; Adult; Fatal Outcome; Female; Fever; Humans; Hypotension; Liver; Liver Failure, Acute; L | 1996 |
[Auxiliary liver transplantation for acute liver failure after intake of 3,4-methylenedioxymethamphetamine ("Ecstasy")].
Topics: Adolescent; Hallucinogens; Humans; Liver; Liver Failure, Acute; Liver Function Tests; Liver Regenera | 1997 |
Ecstasy: a common cause of severe acute hepatotoxicity.
Topics: Adolescent; Adult; Hallucinogens; Humans; Liver Failure, Acute; Male; N-Methyl-3,4-methylenedioxyamp | 1998 |
[Acute liver failure].
Topics: Chemical and Drug Induced Liver Injury; Diagnosis, Differential; Hallucinogens; Humans; Liver Failur | 1998 |